Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). For more information, visit: www.rezolutebio.com.
| Website | http://www.rezolutebio.com |
| Ticker | OTCQB:RZLT |
| Employees | 74 (56 on RocketReach) |
| Founded | 2010 |
| Address | 275 Shoreline Dr. Ste. 500, Redwood City, California 94065, US |
| Phone | +1 303-222-2128 |
| Technologies |
JavaScript
,
HTML
,
PHP
+26 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Diabetes, Health Care, Therapeutics |
| Keywords | Rare Diseases, Rare Disease Therapeutics, Endocrine Disorders, Metabolic Diseases, Clinical Trials, Drug Development, Diabetes Research, Precision Medicine, Targeted Therapies, Innovative Therapies, Pharmaceutical Research, Medical Research, Biotechnology, Healthcare, New Drug Applications |
| Competitors | Novartis, AstraZeneca, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Sangamo Therapeutics, Inc., Lilly India +39 more (view full list) |
Looking for a particular Rezolute, Inc. employee's phone or email?
Daron Evans is the CFO of Rezolute, Inc..
56 people are employed at Rezolute, Inc..
Rezolute, Inc. is based in Redwood City, California.